Malignant melanoma, a cancer that originates in melanin-producing cells, is the deadliest variety of skin cancer. In the past 11 years, immunotherapy has increased the median survival rate of advanced melanoma from nine months to six years. However, it is still a developing treatment. Farida Zakariya, a masters student in[Read More…]
Tag: immunotherapy
Health misinformation: A hidden obstacle to better patient outcomes
The internet has become a widely used source of health information by the public, including cancer patients. However, the quality and reliability of online information vary greatly, leading to misunderstandings of treatments and, ultimately, reduced quality of care for those living with cancer. In a recent paper, Marrah Nicolas-Joseph, U3[Read More…]
A new immunocellular therapy at our doorstep
According to the Canadian Cancer Society, nearly 7,000 Canadians will be diagnosed with leukemia this year with a mortality rate of nearly 50 per cent. Similarly, over 10,000 will be diagnosed with non-Hodgkin’s lymphoma—a specific type of cancer that causes lymphocyte cells to develop abnormally. Many research institutions across the[Read More…]
T-cells take the wheel
In recent years, modern targeted cancer treatments such as chemotherapy, radiation, and surgery have become better at effectively treating the disease. However, these methods continue to be invasive for patients, as they essentially involve racing to kill cancerous cells faster than healthy ones. Fortunately, discoveries in the field of immunotherapy—using the[Read More…]
